Long terminal repeats of human endogenous retrovirus K family (HERV-K) specifically bind host cell nuclear proteins  by Akopov, Sergey B et al.
Long terminal repeats of human endogenous retrovirus K family
(HERV-K) speci¢cally bind host cell nuclear proteins
Sergey B. Akopov*, Lev G. Nikolaev, Pavel P. Khil, Yuri B. Lebedev, Eugene D. Sverdlov
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya 16/10, Moscow 117871, Russia
Received 24 November 1997; revised version received 2 December 1997
Abstract Solitary long terminal repeats (LTRs) of the human
endogenous retroviruses, scattered in several thousand copies
throughout the human genome, are potentially capable of
affecting the expression of closely located genes. To assess their
regulatory potential, the LTR sequences of one of the most
abundant HERV families (HERV-K) were screened for the
presence of binding sites for the host cell nuclear factors using
mobility shift and UV-crosslinking assays. It was shown that the
LTR sequences of two subfamilies harbor a specific binding site
for a complex consisting of at least three proteins, ERF1, ERF2
and ERF3 of 98, 91 and 88 kDa apparent molecular mass,
respectively. This binding site is located in the 5P region of the
LTR U3 element. The preservation of the specific protein binding
site in different HERV-K LTR sequences suggests their possible
role in regulation of nearby located genes.
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1. Introduction
Human endogenous retroviral (HERV) sequences constitute
an estimated 0.1^1% of the whole human genome (see [1^4]
for review). To date, more than 10 distinct HERV families
have been identi¢ed in the human genome. Of them, the
HTDV/HERV-K [5,6] (or HERV-K (CUU), see [2]) family
is considered to be the most active biologically and capable
of forming virions in normal placenta and teratocarcinoma
cells [7^9]. Although only about 50 full-length HERV-K cop-
ies have been identi¢ed so far in the human genome [6], sev-
eral thousand solitary HERV-K-related long terminal repeats
(LTRs) are scattered throughout most human chromosomes
[10]. The detailed mapping of the HERV-K LTRs on human
chromosome 19 [11,12] revealed frequent proximity of the
LTRs and known genes suggesting the possible implication
of the LTRs in the regulation of neighboring cellular genes,
as demonstrated for other HERV families [13^19].
The HERV-K genes are transcribed in a variety of tissues
and cell lines, suggesting that at least some of the HERV-K
LTRs are active as promoters (see [3,7] and references there-
in). To be able to regulate cellular genes, the LTRs should
contain some regulatory sequences with the capacity to bind
regulatory proteins, e.g. transcription factors.
In this work we tested a near full-length HERV-K LTR for
the ability to bind speci¢cally cellular protein factors. We
detected three proteins that form a speci¢c complex with the
LTR and can be the factors necessary for the LTR to perform
its regulatory function.
2. Materials and methods
2.1. Cell culture
Jurkat and CHO (Chinese hamster ovary) cells were grown in
RPMI 1640 medium supplemented with 10% fetal calf serum, penicil-
lin (100 U/ml) and streptomycin (0.1 mg/ml), other cell lines were
grown under the same conditions but in DMEM.
2.2. Oligonucleotides
Oligonucleotides and PCR primers (Table 1) were synthesized using
an ASM-102U DNA synthesizer (Biosan, Russia).
2.3. Nuclear extracts
Nuclear extracts from cultured cells were prepared as described [20]
with modi¢cations [21]. For DNase I footprinting, Jurkat cell nuclear
extract was additionally puri¢ed on a heparin-agarose column. 1 ml of
the extract (10 mg/ml in protein) was diluted to 1 mg/ml with 20 mM
HEPES-KOH, pH 7.9, 20% glycerol, 100 mM KCl, 0.5 mM EDTA,
1 mM dithiothreitol, 0.5 mM PMSF and then 0.66 volume of water
was added to make the ¢nal KCl concentration 60 mM. The extract
was then passed ¢ve times through a 2.5-ml heparin-agarose column
equilibrated with nuclear extract bu¡er or NEB (12 mM HEPES-
KOH, pH 7.9, 12% glycerol, 60 mM KCl, 0.3 mM EDTA, 0.6 mM
dithiothreitol, 0.5 mM PMSF). The column was washed with 20 ml
NEB and then with 3 ml NEB additionally supplied with KCl up to a
¢nal concentration of 360 mM. Proteins retained on the column were
eluted with NEB containing 0.66 M KCl, dialyzed overnight against
100 volumes of NEB with 30 WM leupeptin and 0.5 mM PMSF at
4‡C, roughly 5-fold concentrated using a Sartorius Centrisart 1
(10000) protein concentrator and stored frozen at 370‡C.
2.4. Mobility shift assay and UV-crosslinking
LTR fragments for the mobility shift assay were radioactively la-
beled using PCR with a corresponding primer pair as described earlier
[22]. Complementary oligonucleotides were annealed, labeled by ¢ll-
ing-in the ends with Klenow enzyme and puri¢ed by polyacrylamide
gel electrophoresis as described [23].
Mobility shift was performed as described [24] with modi¢cations
[23]. Two-dimensional mobility shift UV-crosslinking analysis was
performed as follows. Approximately 200 000 cpm of labeled dou-
ble-stranded oligonucleotide was mixed with 5 Wg of poly-d(IC)-
poly-d(IC) and 50 Wg of nuclear extract proteins in a ¢nal volume
of 60 Wl NEB supplied with 3 WM leupeptin, and incubated for 20 min
at room temperature. The mixture was applied to the ¢rst dimension
10% polyacrylamide gel prepared in 50 mM Tris-borate bu¡er, pH
8.3, 0.5 mM EDTA, and separated in the same bu¡er. The gel was
irradiated with a UV lamp (254 nm, 6 WW/cm2) for 3 min, an auto-
radiographically localized gel strip was cut out of the gel and im-
mersed in 50 mM Tris-HCl, pH 6.8, 1% SDS, 2% 2-mercaptoethanol,
0.025% bromophenol blue for 15 min at 55‡C. The gel strip was then
placed on the top of a 12% SDS-polyacrylamide gel [25] and proteins
crosslinked to the labeled oligonucleotide were separated in the sec-
ond dimension according to their molecular masses. The oligonucleo-
tides crosslinked to the proteins do not signi¢cantly change their
electrophoretic mobility [26].
2.5. DNase I footprinting
To obtain either coding or non-coding end-labeled strands, an
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LTR-F/590-R fragment (333 bp in length) was PCR-ampli¢ed using
5P-end labeled LTR-F or 590-R primers (see Fig. 1 and Table 1). To
this end, 10 pmol of each primer was incubated with 5 WCi of
[Q-32P]ATP (Institute for Physics and Power Engineering, Obninsk,
Russia) and 10 U of polynucleotide kinase (Promega) in 15 Wl of
50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 0.5 mM dithiothreitol,
50 Wg/ml bovine serum albumin at 37‡C for 45 min. 10 pmol of the
labeled primer was added to the PCR mixture containing 10 pmol of
the corresponding unlabeled primer, 5 ng of template plasmid DNA,
250 WM each dNTP, 1.5 mM MgCl2, 1UPCR reaction bu¡er (Perkin-
Elmer Cetus) and 2 U of the AmpliTaq DNA polymerase in a ¢nal
volume of 50 Wl. PCR ampli¢cation was performed for 18 cycles of
the following pro¢le: 94‡C for 48 s, 60‡C for 48 s, 72‡C for 60 s. The
whole reaction mixture was then applied to a 10% non-denaturing
polyacrylamide gel, the labeled fragments localized by autoradiog-
raphy, cut out from the gel, and eluted. The footprinting was done
as described [27].
2.6. Database search and alignment of sequences
Full-length LTRs of the HERV-K family were identi¢ed in Gen-
Bank using the BLAST WWW server at NCBI (available at http://
www.ncbi.nlm.gov/BLAST). The subfamily-speci¢c consensus sequen-
ces of HERV-K LTR were used as search probes. LTRs were aligned
using ClustalW ver. 1.6 [28] and the alignment was then manually
re¢ned in GDE ver. 2.0. [29]. For transcription factor search the
TRANSFAC (ver. 3.1) database [30] was used with the help of the
TESS Internet search tool (http://agave.humgen.upenn.edu/tess/in-
dex.html).
3. Results and discussion
Fragments of the speci¢c LTR representing the ‘old’
HERV-K subfamily and mapped to the chromosome 19p12
locus [31] were ampli¢ed by PCR using several primer pairs.
Positions of primers and PCR fragments within the LTR se-
quences are shown in Fig. 1, and sequences of the primers are
presented in Table 1. Overlapping fragments of the whole
LTR were labeled in the course of the PCR reaction using
one labeled nucleotide [22], gel-puri¢ed, incubated with Jurkat
cell nuclear extract and applied to a non-denaturing poly-
acrylamide gel (Fig. 2). Of four overlapping fragments tested,
a strong protein binding band (indicated by an arrow in Fig.
2) was detected for two fragments ampli¢ed with the primer
pairs LTR-F/6A12-R and LTR-F/590-R. These results located
an apparently unique binding site of the LTR between the
LTR-F and 6A12-F primer binding sites in a fragment of
230 bp within the LTR U3 region.
To further characterize the protein binding site, DNase I
protection experiments were performed (Fig. 3). The protected
sequence of about 28 bp was located in the 5P part of the U3
region. It is £anked by DNAse I hypersensitive sites and spans
both previously identi¢ed putative enhancer core and gluco-
corticoid receptor binding sites [6,10]. The most e⁄ciently
protected sequence was situated immediately 5P to these two
sites.
To assess general conservation and stability of this region in
evolution, the alignment of the full-length sequences of the
HERV-K LTRs found in GenBank was done as described
in Section 2. The region of interest represented by six charac-
teristic sequences of the alignment is shown in Fig. 4A. The
main feature of the region is the presence of a 6-bp site deleted
from the ¢rst three LTRs of the younger subfamily but not
from the other three LTRs of the older subfamily (see [31] for
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Table 1
Structures and description of oligonucleotides
Oligonucleotide Description Structure 5P-3P
LTR-F LTR 5P-end primer TGTAGAAAGAAGTAGACATAGGAGACT
LTR-R LTR 3P-end primer AAAGACACAGAGACAAAGTATAGA
590-R LTR internal primer GCCATATTTCAGACTATCACATGG
590-CR Complementary to 590-R CCATGTGATAGTCTGAAATATGGC
6A12-F LTR internal primer ATCACCATTCTCCCAGTCTCA
6A12-R LTR internal primer TTCACTAATCCTCCTCAGCCACA
LTR1 LTR protein binding site, coding AATAGGAGACTCCATTTTGTTCTGTACTAAGA
LTR1-C LTR protein binding site, non-coding TTTCTTAGTACAGAACAAAATGGAGTCTCCTA
LTR2 LTR protein binding site, coding AATAAGAGACTCCATTTTGAAAAAGACCTGTACTTTAA
LTR2-C LTR protein binding site, non-coding TTTTAAAGTACAGGTCTTTTTCAAAATGGAGTCTCTTA
HIV HIV-1 enhancer core, coding CTACAAGGGACTTTCCGCTGGGGACTTTCCAGGG
HIV-C HIV-1 enhancer core, non-coding AGCCCTGGAAAGTCCCCAGCGGAAAGTCCCTTGT
HIVM Mutant HIV-1 enhancer, coding CTACAACTCACTTTCCGCTGCTCACTTTCCAGGG
HIVM-C Mutant HIV-1 enhancer, non-coding AGCCCTGGAAAGTGAGCAGCGGAAAGTGAGTTGT
Fig. 1. Structure of the HERV-K LTR and positions of PCR primers and resulting fragments. Solid lines represent fragments capable of bind-
ing nuclear proteins (see text).
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characterization of these two subfamilies). As seen in Fig. 3,
this deletion lies in the very center of the region protected by
protein(s). To study the role of this deletion in the protein
binding, two di¡erent double-stranded oligonucleotides repre-
senting the consensus of these two groups of sequences were
designed (Table 1) and then used for the electrophoretic mo-
bility shift assay (Fig. 4B). Lane 1 shows the result of the
mobility shift using LTR1/LTR1-C double-stranded oligonu-
cleotide (see Table 1 for sequence) as a labeled probe and
nuclear extract from Jurkat cells. This oligonucleotide was
designed based on the consensus sequence of the younger
LTR subfamily characterized by the presence of the 6-bp
AAAAGA deletion (Fig. 4A). Apart from two major visible
shifted a and b bands (Fig. 4B), several faint bands could also
be detected. Other lanes show the results of similar mobility
shift experiments but in the presence of 10- and 20-fold molar
excess of various non-labeled competitors which either con-
tained (LTR1/LTR1-C oligonucleotide, identical to the probe)
or did not contain (LTR2/LTR2-C oligonucleotide) the 6-bp
deletion (lanes 2, 3 and 3, 4, respectively). Lanes 6 and 7, and
lanes 8 and 9 illustrate competitor properties of HIV/HIV-C
and HIVM/HIVM-C oligonucleotides representing the native
and mutated enhancer regions of human immunode¢ciency
virus type 1 [23]. Fig. 4B demonstrates that the protein(s) in
the major shifted band a is readily displaced from its com-
plexes with labeled oligonucleotides by relatively small molar
excesses of both oligonucleotide competitors irrespective of
the presence of the 6-bp deletion. At the same time, a func-
tional lentiviral enhancer sequence known to bind several
transcription factors, including NF-UB [23], does not compete
for the protein factor(s) binding the LTR sequence. The less
intense shifted band b behaved di¡erently. Its intensity was
changed insigni¢cantly upon addition of both HERV-K and
HIV-1 oligonucleotides, indicating low binding speci¢city of
the protein in this complex. Therefore, only protein(s) respon-
sible for the appearance of the shifted band a can be consid-
ered to speci¢cally bind the HERV-K LTR.
The mobility shift using a longer double-stranded oligonu-
cleotide LTR2/LTR2-C as a labeled probe and a shorter one
(LTR1/LTR1-C) as a competitor showed that the latter is
similarly capable of displacing the protein(s) from the com-
plex formed by the former (data not shown). Therefore, de-
spite signi¢cant di¡erences between the binding region pri-
mary structures, both subfamilies of the HERV-K LTRs are
capable of forming a speci¢c complex with the same protein(s)
when incubated with the nuclear extract from Jurkat cells.
Similar electrophoretic mobility shift experiments with nuclear
extracts from HeLa and CHO cell lines apparently produced
the same two major shifted bands, with slightly less mobility
in the latter case (data not shown). Therefore, the proteins
that form complexes a and b with the HERV-K LTR se-
quence seem to be present in di¡erent human and mammalian
cell types.
To characterize the protein-DNA complexes in more detail,
the UV-crosslinking technique was employed [21^23]. The
protein-DNA complexes were resolved by a mobility shift
gel (as in Fig. 4B), the corresponding gel strip was cut out,
irradiated with UV light, and the crosslinked complexes of
proteins with labeled oligonucleotides were separated in the
second dimension according to their molecular masses (Fig.
4C). The non-speci¢c complex b (Fig. 4B) produced a single
protein spot (b in Fig. 4C) with an apparent molecular mass
of 56 kDa, whereas the major mobility shift band a produced
three protein spots corresponding to 98, 91 and 81 kDa. All
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Fig. 3. DNase I protection of the HERV-K LTR fragment LTR-F/
590-R. Lane 1, A+G sequence marker. Lane 2, 50 Wg of the puri¢ed
nuclear extract protein added. Lane 3, no protein added.
Fig. 2. Electrophoretic mobility shift assay using the HERV-K LTR
fragments as probes and nuclear extracts from Jurkat cells. The
lanes with uneven and even numbers contained 1 and 3 Wg of the
extract protein, respectively. Lanes 1, 2: the probe produced by pri-
mers 590-CR and LTR-R, length 549 bp. Lanes 3, 4: the probe
produced by primers LTR-F and 6A12-R, length 294 bp. Lanes 5,
6: the probe produced by primers LTR-F and 590-R, length 333
bp. Lanes 7, 8: the probe produced by primers 6A12-F and 6A12-
R, length 201 bp. The arrow indicates a single major protein-DNA
complex.
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spots were located strictly on the same vertical line, indicating
that they were part of the same DNA-protein complex. All
three proteins could be crosslinked to DNA by UV light,
which means that they are in close contact with it. This can
explain why the region protected from the DNase I cleavage
by these proteins is rather long (about 30 bp). We designated
the proteins ERF1, ERF2 and ERF3 (endogenous retrovirus
factors) in order of decreasing molecular masses. However,
the complex might also include other protein(s) participating
in the binding through protein-protein interactions.
An extensive search of the TRANSFAC database [30] did
not reveal proteins both capable of binding our oligonucleo-
tides and having molecular masses close to those of ERF1,
ERF2 and ERF3 proteins.
Although the characterization of the identi¢ed proteins is a
matter for further experiments, the results presented here
clearly demonstrate that di¡erent kinds of HERV-K LTRs
preserved the potential for speci¢c interaction with cellular
proteins that is a prerequisite for their involvement in func-
tional interplay in the genome.
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